FOUNDAYO 5.5 mg/1
orforglipron · TABLET, FILM COATED · Eli Lilly and Company
Foundayo (orforglipron) is an oral tablet taken by mouth that comes in a 5.5 mg strength and requires a prescription. Your doctor can provide information about what condition this medication treats and how to use it properly.
Key Facts
- Brand Name
- FOUNDAYO
- Generic Name
- orforglipron
- NDC Code (Product)
0002-4794- Manufacturer
- Eli Lilly and Company
- Strength
- 5.5 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA220934
- Marketing Start
- 04/01/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is FOUNDAYO used for?
Foundayo (orforglipron) is an oral tablet taken by mouth that comes in a 5.5 mg strength and requires a prescription. Your doctor can provide information about what condition this medication treats and how to use it properly.
Is FOUNDAYO a controlled substance?
FOUNDAYO is not classified as a controlled substance by the DEA.
What is the generic name for FOUNDAYO?
The generic name for FOUNDAYO is orforglipron. There are no other listed brand versions of orforglipron.
What is the NDC code for FOUNDAYO 5.5 mg/1?
The NDC (National Drug Code) for FOUNDAYO 5.5 mg/1 is 0002-4794, listed by Eli Lilly and Company.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)